1 duplicate copy in the archive
AAVL: (BN) Avalanche Drops as Gene Therapy Trial Miss High Expectation [CI (Vahe Stepanian, 6/16/2015)
Title Matchefta-efta01368452
Case Filesd-10-EFTA01368452Dept. of JusticeAAVL: (BN) Avalanche Drops as Gene Therapy Trial Miss High Expectation [CI (Vahe Stepanian, 6/16/2015)
June 16, 20151p
Case File
sd-10-EFTA01368452Dept. of JusticeAAVL: (BN) Avalanche Drops as Gene Therapy Trial Miss High Expectation [CI (Vahe Stepanian, 6/16/2015)
Email
819.76/19.86K From: Vahe Stepanian Sent: 6/16/2015 10:02:02 AM To: Jeffrey Epstein Deevacation@gmailcom) CC: Daniel Sabba • Ariane Dwyer Stewart Oldfield ; Richard Kahn Subject: AAVL: (BN) Avalanche Drops as Gene Therapy Trial Miss High Expectation [CI Classification: Confidential Jeffrey - we are following up with the below news regarding AAVL. The stock is trading down $19.11 to $19.7657 per the Bloomberg screenshot below. Please let us know how you would like to proceed with
Date
June 16, 2015
Source
Dept. of Justice
Reference
sd-10-EFTA01368452
Pages
1
Persons
0
Integrity
Loading document viewer...
Forum Discussions
This document was digitized, indexed, and cross-referenced with 1,800+ persons in the Epstein files. 100% free, donor-supported, and independent. Donors see no ads.
Support This ProjectSupported by 1,550+ people worldwide
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.